BDNF and Alzheimer disease: This narrative review examines ketamine's emerging role in AD, focusing on its mechanisms of action, including modulation of glutamatergic transmission, enhancement of synaptic plasticity via brain-derived neurotrophic factor (BDNF) pathways, and attenuation of neuroinflammatory processes.